Stage III Breast Cancer Clinical Trials

48 clinical trials for Stage III Breast Cancer across international registries, including 9 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Elacestrant for Treating ER+/HER2- Breast Cancer Patients With ctDNA Relapse (TREAT ctDNA) — RECRUITING · PHASE3
• TeleHealth Resistance Exercise Intervention to Preserve Dose Intensity and Vitality in Elder Breast Cancer Patients — RECRUITING · NA
• Improving Exercise Capacity With a Tailored Physical Activity Intervention — RECRUITING · NA
• A Study of Revaree Plus in People With Breast Cancer — RECRUITING · PHASE4
• [18F]FES PET/CT for the Detection of Distant Metastasis in Low-grade ER-positive Stage III Breast Cancer — RECRUITING · PHASE2
• Trastuzumab Deruxtecan Alone or in Combination With Anastrozole for the Treatment of Early Stage HER2 Low, Hormone Receptor Positive Breast Cancer — RECRUITING · PHASE2
• Predicting BReast cAncer Response to neoadjuVant Therapy by ctDNA Assessment — RECRUITING
• A Study of Disappearing Markers for Daily Radiation Treatment Delivery for Breast Cancer Patients. — RECRUITING · NA
• Postoperative Radiotherapy in Breast Cancer- Concurrent or Sequential With Chemotherapy — RECRUITING · PHASE3
• Acupuncture Pilot Study for Cancer-related Cognitive Function — ACTIVE_NOT_RECRUITING · PHASE2
• Platinum in Treating Patients With Residual Triple-Negative Breast Cancer Following Neoadjuvant Chemotherapy — ACTIVE_NOT_RECRUITING · PHASE3
• Researching the Effect of Exercise on Cancer — ACTIVE_NOT_RECRUITING · NA
• Paclitaxel & Cyclophosphamide With or Without Trastuzumab Before Surgery in Treating Previously Untreated Breast Cancer — COMPLETED · PHASE2
• Niraparib + Dostarlimab In BRCA Mutated Breast Cancer — ACTIVE_NOT_RECRUITING · PHASE2
• HER2 Directed Dendritic Cell Vaccine During Neoadjuvant Therapy of HER2+Breast Cancer — COMPLETED · PHASE1
• T-DM1+Pertuzumab in Pre-OP Early-Stage HER2+ BRCA — ACTIVE_NOT_RECRUITING · PHASE2
• Avelumab With Binimetinib, Sacituzumab Govitecan, or Liposomal Doxorubicin in Treating Stage IV or Unresectable, Recurrent Triple Negative Breast Cancer — ACTIVE_NOT_RECRUITING · PHASE2
• A Pilot Study of Acupuncture for Chemotherapy-induced Peripheral Neuropathy in Breast Cancer Patients — COMPLETED · NA
• Alisertib With or Without Fulvestrant in Treating Patients With Locally Advanced or Metastatic, Endocrine-Resistant Breast Cancer — COMPLETED · PHASE2
• Vaccine Therapy in Treating Patients With HER2-Negative Stage III-IV Breast Cancer — ACTIVE_NOT_RECRUITING · PHASE1
• Mindfulness-based Intervention for Depressive Symptoms Sent Via Text (MINDSET) — NOT_YET_RECRUITING · NA
• MARGetuximab Or Trastuzumab (MARGOT) — ACTIVE_NOT_RECRUITING · PHASE2
• Exercise in Targeting Metabolic Dysregulation in Stage I-III Breast or Prostate Cancer Survivors — TERMINATED · NA
• SHR-A1811 for HER2-positive Breast Cancer With Suboptimal Neoadjuvant Response — NOT_YET_RECRUITING · PHASE2
• Carevive Survivor Care Planning System in Improving Quality of Life in Breast Cancer Survivors — COMPLETED · NA
• Defining the Clinical Potential of Mass Response As a Biomarker for Patient Tumor Sensitivity to Drugs — WITHDRAWN
• Vaccine Therapy in Preventing Cancer Recurrence in Patients With Non-Metastatic, Node Positive, HER2 Negative Breast Cancer That is in Remission — COMPLETED · PHASE1
• Detection and Prevention of Anthracycline-Related Cardiac Toxicity With Concurrent Simvastatin — TERMINATED · PHASE2
• Ultrasound in Detecting Taxane-Induced Neuropathy in Patients With Breast Cancer — COMPLETED · NA
• Impact of 18F-FDG PET-CT Versus Conventional Staging in the Management of Patients Presenting With Clinical Stage III Breast Cancer — COMPLETED · NA
• Aerobic and Strength Training Exercise in Improving Fitness and Arm Health During and After Radiation Therapy in Patients With Stage II-III Breast Cancer — COMPLETED · NA
• Ask Questions (ASQ):Implementation of a Communication Intervention — COMPLETED · NA
• 4-1BB Agonist Monoclonal Antibody PF-05082566 With Trastuzumab Emtansine or Trastuzumab in Treating Patients With Advanced HER2-Positive Breast Cancer — COMPLETED · PHASE1
• Copanlisib, Letrozole, and Palbociclib in Treating Patients With Hormone Receptor Positive HER2 Negative Stage I-IV Breast Cancer — TERMINATED · PHASE1
• Preoperative Hormone Therapy for Postmenopausal Women With ER+ Clinical Stage T2-4 Tumors — COMPLETED · PHASE2
• Living Well After Breast Surgery — COMPLETED · NA
• Atezolizumab and Cobimetinib or Idasanutlin in Participants With Stage IV or Unresectable Recurrent Estrogen Receptor Positive Breast Cancer — TERMINATED · PHASE1
• Study of AVB-620 in Women With Primary, Nonrecurrent Breast Cancer Undergoing Surgery — COMPLETED · PHASE2
• Acceptance and Commitment Therapy in Improving Well-Being in Patients With Stage III-IV Cancer and Their Partners — COMPLETED · NA
• Pembrolizumab and Capecitabine in Treating Patients With Locally Advanced or Metastatic Triple Negative or Hormone-Refractory Breast Cancer That Cannot Be Removed by Surgery — OTHER · PHASE2
• Vorinostat in Treating Women Who Are Undergoing Surgery For Newly Diagnosed Stage I -III Breast Cancer — COMPLETED · PHASE2
• Exercise Intervention in Targeting Adiposity and Inflammation With Movement to Improve Prognosis in Breast Cancer — WITHDRAWN · NA
• A Trail of Neoadjuvant Endostar in Combination With Chemotherapy in Breast Cancer — OTHER · PHASE2
• Preoperative Herceptin and Navelbine for Breast Cancer — COMPLETED · PHASE2
• Trial With Autologous Dendritic Cell Vaccination in Patients With Stage II-III HER2 Negative Breast Cancer — COMPLETED · PHASE2
• Capecitabine in Women With Operable Breast Cancer — TERMINATED · PHASE2
• Neoadjuvant Trial of Capecitabine for Axillary Lymph Node Positive Operable Breast Cancer — OTHER · PHASE2
• A Study of Vorinostat and Tamoxifen in Newly Diagnosed Breast Cancer — TERMINATED · PHASE2

Refine this search